MPM BioImpact LLC

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Value $
$704M
Signature - Title
Christopher Wolf - Chief Financial Officer
Location
Boston, MA
Summary
This page shows a list of all the recent 13F filings made by MPM BioImpact LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. MPM BioImpact LLC reported 47 stock holdings with total value $704M as of Q4 2024. Top holdings included CGEM, CRNX, EWTX, INSM, and NTRA.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 47 $704M +$199M -$70.5M +$129M CGEM, CRNX, EWTX, INSM, NTRA 13F-HR 2/14/2025, 04:20 PM
Q3 2024 43 $667M +$122M -$114M +$8.21M CGEM, INSM, OLMA, RNA, CRNX 13F-HR 11/12/2024, 07:40 PM
Q2 2024 44 $644M +$158M -$64.2M +$93.8M CGEM, INSM, OLMA, ITOS, CRNX 13F-HR 8/14/2024, 11:32 AM
Q1 2024 36 $483M +$161M -$77.7M +$83.7M GERN, IOVA, ZNTL, ITOS, STRO 13F-HR 5/15/2024, 04:22 PM
Q4 2023 32 $427M +$25.4M -$32.5M -$7.07M CGEM, IOVA, OLMA, GERN, ITOS 13F-HR 2/13/2024, 04:06 PM
Q3 2023 39 $375M +$58.6M -$121M -$62.5M CGEM, OLMA, GERN, RPTX, ITOS 13F-HR 11/14/2023, 04:38 PM
Q2 2023 41 $497M +$138M -$67.7M +$70.4M CGEM, ISEE, KDNY, GERN, RETA 13F-HR 8/14/2023, 12:19 PM
Q1 2023 31 $385M +$43.1M -$16.5M +$26.6M CGEM, PRVB, ISEE, ITOS, INBX 13F-HR 5/12/2023, 01:02 PM
Q4 2022 33 $385M +$49.5M -$6.96M +$42.6M CGEM, ITOS, INBX, RPTX, ISEE 13F-HR 2/14/2023, 11:41 AM
Q3 2022 38 $422M +$74.3M -$6.26M +$68M CGEM, ITOS, INBX, VERV, NTLA 13F-HR 11/14/2022, 09:22 AM
Q2 2022 37 $360M +$43M -$1.18M +$41.8M CGEM, ITOS, RPTX, MRUS, NTLA 13F-HR 8/11/2022, 05:27 PM
Q1 2022 37 $373M +$23.5M -$5.71M +$17.8M CGEM, ITOS, MRUS, RPTX, HARPXXXX 13F-HR 5/13/2022, 12:05 PM
Q4 2021 33 $549M +$39.1M -$19.6M +$19.6M CGEM, ITOS, RPTX, MEIPXXXX, MRUS 13F-HR 2/11/2022, 03:37 PM
Q3 2021 33 $645M +$155M -$13.2M +$142M CGEM, ITOS, RPTX, HOWL, TCRR 13F-HR 11/12/2021, 06:19 PM
Q2 2021 14 $609M +$41.6M -$25M +$16.7M CGEM, ITOS, TCRR, RPTX, HARPXXXX 13F-HR 8/13/2021, 09:24 AM
Q1 2021 13 $796M +$330M -$33.7M +$296M CGEM, HARPXXXX, ITOS, TCRR, RPTX 13F-HR 5/13/2021, 03:46 PM
Q4 2020 13 $569M +$76.8M -$5.68M +$71.2M TCRR, RPTX, ITOS, ONCR, HARPXXXX 13F-HR/A 2/24/2021, 03:55 PM
Q4 2020 1 $26.8K 13F-HR 2/16/2021, 05:45 AM
Q3 2020 12 $415M RPTX, TCRR, HARPXXXX, ITOS, EPZM Restatement 11/19/2020, 01:36 PM
Q2 2020 1 $41.9K 13F-HR 8/12/2020, 12:12 PM
Q1 2020 10 $164M +$13.8M +$13.8M HARPXXXX, EPZM, TCRR, GTHX, TPTX 13F-HR 5/13/2020, 12:16 PM
Q4 2019 12 $282M HARPXXXX, EPZM, TCRR, GTHX, ARQL 13F-HR 2/14/2020, 02:03 PM